Literature DB >> 17151820

Hyperplasia suppressor gene associates with smooth muscle alpha-actin and is involved in the redifferentiation of vascular smooth muscle cells.

Guang-Jian Jiang1, Mei Han, Bin Zheng, Jin-Kun Wen.   

Abstract

Vascular smooth muscle cell (VSMC) differentiation and phenotypic modulation are characterized by changes in gene expression for smooth muscle (SM) marker contractile proteins such as SM alpha-actin and SM22alpha. Hyperplasia suppressor gene (HSG) is a potent VSMC proliferation-inhibiting factor; however, it is not known if HSG is involved in the redifferentiation of VSMCs. Here, the redifferentiation of the dedifferentiated VSMCs was induced by serum withdrawal or all-trans retinoic acid (atRA), HSG gene expression and its role in VSMC phenotypic modulation were studied by reverse transcription - polymerase chain reaction, Western blotting, and cell migration assay. The results indicated that HSG gene expression increased significantly during VSMC redifferentiation induced by serum deprivation or atRA and peaked at 24 h, then was maintained at higher levels. Meanwhile, SM marker contractile proteins SM alpha-actin and SM22alpha were increased by more than 2-fold. Coimmunoprecipitation and immunofluorescent experiments revealed that anti-HSG antibody could precipitate SM alpha-actin, and HSG and SM alpha-actin colocalized within the cytoplasm of differentiated VSMCs. Migration activity of VSMCs was dramatically suppressed after cells were transfected with HSG expression plasmids. These findings suggested that HSG is associated with SM alpha-actin in VSMC cytoplasm, and is involved in VSMC differentiation and migration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17151820     DOI: 10.1007/s00380-006-0914-4

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  16 in total

Review 1.  Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies.

Authors:  Victor J Dzau; Ruediger C Braun-Dullaeus; Daniel G Sedding
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

Review 2.  A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies.

Authors:  J S Forrester; M Fishbein; R Helfant; J Fagin
Journal:  J Am Coll Cardiol       Date:  1991-03-01       Impact factor: 24.094

Review 3.  Cell cycle progression: new therapeutic target for vascular proliferative disease.

Authors:  R C Braun-Dullaeus; M J Mann; V J Dzau
Journal:  Circulation       Date:  1998-07-07       Impact factor: 29.690

Review 4.  Regulation of differentiation/maturation in vascular smooth muscle cells by hormones and growth factors.

Authors:  G K Owens; G Wise
Journal:  Agents Actions Suppl       Date:  1997

Review 5.  Regulation of differentiation of vascular smooth muscle cells.

Authors:  G K Owens
Journal:  Physiol Rev       Date:  1995-07       Impact factor: 37.312

6.  Recruitment of serum response factor and hyperacetylation of histones at smooth muscle-specific regulatory regions during differentiation of a novel P19-derived in vitro smooth muscle differentiation system.

Authors:  I Manabe; G K Owens
Journal:  Circ Res       Date:  2001-06-08       Impact factor: 17.367

7.  Comparison of gene expression patterns and migration capability at quiescent and proliferating vascular smooth muscle cells stimulated by cytokines.

Authors:  Jin-kun Wen; Mei Han; Bin Zheng; Shu-Li Yang
Journal:  Life Sci       Date:  2002-01-04       Impact factor: 5.037

8.  Regulation of SM22 alpha expression by arginine vasopressin and PDGF-BB in vascular smooth muscle cells.

Authors:  Nihal Kaplan-Albuquerque; Chrystelle Garat; Vicki Van Putten; Raphael A Nemenoff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-06-26       Impact factor: 4.733

9.  Regulation of smooth muscle alpha-actin promoter by vasopressin and platelet-derived growth factor in rat aortic vascular smooth muscle cells.

Authors:  V Van Putten; X Li; J Maselli; R A Nemenoff
Journal:  Circ Res       Date:  1994-12       Impact factor: 17.367

10.  The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells.

Authors:  Junbao Du; Yan Hui; Yiufai Cheung; Geng Bin; Hongfeng Jiang; Xiaobo Chen; Chaoshu Tang
Journal:  Heart Vessels       Date:  2004-03       Impact factor: 2.037

View more
  3 in total

Review 1.  An overview of potential molecular mechanisms involved in VSMC phenotypic modulation.

Authors:  Ming-Jie Zhang; Yi Zhou; Lei Chen; Yan-Qin Wang; Xu Wang; Yan Pi; Chang-Yue Gao; Jing-Cheng Li; Li-Li Zhang
Journal:  Histochem Cell Biol       Date:  2015-12-26       Impact factor: 4.304

2.  Inhibition of cyclooxygenase-2 modulates phenotypic switching of vascular smooth muscle cells during increased aortic blood flow.

Authors:  Jun-Neng Roan; Yu-Chuan Tsai; I-Wen Chen; Shih-Wei Chang; Chien-Chi Huang; Chen-Fuh Lam
Journal:  Heart Vessels       Date:  2011-05-17       Impact factor: 2.037

3.  Krüppel-like factor 4 interacts with p300 to activate mitofusin 2 gene expression induced by all-trans retinoic acid in VSMCs.

Authors:  Rui Zhang; Mei Han; Bin Zheng; Ying-jie Li; Ya-nan Shu; Jin-kun Wen
Journal:  Acta Pharmacol Sin       Date:  2010-08-16       Impact factor: 6.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.